Outliers: The FDA follows the EMA [BE/BA News]

posted by jag009  – NJ, 2019-03-06 19:23  – Posting: # 20002
Views: 720

Hi Helmut,

So they effectively killed off the re-dose/re-challenge study then?
I spoke to a colleague earlier this year and he said FDA no longer wants to see re-challenge study...

John

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,685 posts in 4,176 threads, 1,351 registered users;
online 7 (0 registered, 7 guests [including 3 identified bots]).
Forum time (Europe/Vienna): 01:05 CEST

Normality is a myth; there never was, and never will be,
a normal distribution.    Roy C. Geary

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5